COVID-19 Vaccination in Patients With Inflammatory Bowel Disease: Communiqué From the Canadian Association of Gastroenterology

J Can Assoc Gastroenterol. 2021 Jan 27;4(1):49. doi: 10.1093/jcag/gwaa046. eCollection 2021 Feb.

Frances Tse^{1

2}, Paul Moayyedi^{1

3}, Kevin A Waschke^{4

5}, Mark MacMillan^{2

6}, Nauzer Forbes^{2

7}, Matthew W Carroll^{2

8}, Nicholas Carman^{2

9}, Grigorios I Leontiadis^{1

2}

¹ Division of Gastroenterology, McMaster University, Hamilton, Ontario, Canada.
² Clinical Affairs Committee, Canadian Association of Gastroenterology.
³ President Elect, Canadian Association of Gastroenterology.
⁴ President, Canadian Association of Gastroenterology.
⁵ Division of Gastroenterology and Hepatology, Department of Medicine, McGill University, Montreal, Quebec, Canada.
⁶ Gastroenterology, Dr. Everett Chalmers Regional Hospital, Dalhousie University, Memorial University, St. John's, Newfoundland and Labrador, Canada.
⁷ Division of Gastroenterology and Hepatology, University of Calgary, Calgary, Alberta, Canada.
⁸ Division of Gastroenterology, Hepatology and Nutrition, Department of Pediatrics, University of Alberta, Edmonton, Alberta, Canada.
⁹ Division of Gastroenterology, Hepatology and Nutrition, Department of Pediatrics, University of Ottawa, Ottawa, Ontario, Canada.

No abstract available